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Sickle cell disease is the most common inherited hemoglobin disorder worldwide. It is caused by a point mutation at 6th codon of the β-globin gene where glutamic acid is replaced 
by valine. Under hypoxic conditions, the red cells become rigid 
and sticky and appear like a crescent (sickle) shape. The severity 
due to sickle cell disease varies from asymptomatic to severe 
disease manifestation and death. Despite several advances in 
treatment strategies, patients with sickle cell disease are associated 
with multiple morbidities and early mortality. Most of the patients 
with sickle cell disease show the symptoms of repeated painful 
events and severe anemia which called for medical emergency.
The state of Odisha situated in Eastern India is a highly 
prevalent zone for sickle cell gene, where sickle cell disease 
considered as a major public health problem [1]. In a study 
undertaken in the tribal rich area of this state, the frequency of 
sickle cell gene was found to be 13.1% [2]. Despite high level 
of fetal hemoglobin (HbF), around 60% of these patients suffer 
from severe disease manifestation. The signs and symptoms of 
patients with sickle cell disease depend on the age of the patients, 
geographical area, comorbidity factors like infection, etc. Due 
to relative asplenic state and abnormal humoral immunity, 
infection was a major cause of morbidity and mortality in these 
patients [3,4]. There is a paucity of the literature on incidence of 
various clinical signs and symptoms on Indian adults with sickle 
cell disease, especially during hospitalization and majority of 
studies were focused to children with inconsistent results [5].
This study was carried out to analyze the different clinical 
spectrum and morbidity factors responsible for hospitalization in 
patients with sickle cell disease.
CASE SERIES
The cases were enrolled in the Department of Internal Medicine 
during January 2014–December 2014. This tertiary health-
care facility caters to a population of 12 million residing at 
Western districts of Odisha state and Eastern part of the state of 
Chhattisgarh. This study was approved by the Institutional Ethical 
Committee and was granted ethical clearance. Written informed 
consent was obtained from all participants.
In a routine basis, all the patients admitted in this department 
during the study period were screened for sickle cell disease at sickle 
cell clinic of this hospital. Primary screening of suspected cases was 
carried out by sickling slide test and hemoglobin electrophoresis. 
Patients having “positive” sickling slide test and an “SS” pattern 
in the hemoglobin electrophoresis test were subjected to cation 
exchange - high-performance liquid chromatography using the 
VARIANT II Haemoglobin testing system; Bio-Rad Laboratories, 
Hercules, CA, USA, as per the manufacturer’s guideline for the 
confirmatory test. After the final confirmation, we had recruited 
40 patients with sickle cell disease for further analysis.
Along with the diagnosis of sickle cell disease, other 
examinations were also conducted, which includes complete 
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blood count, biochemical parameters (serum urea, serum 
creatinine, serum bilirubin-total, serum bilirubin direct, serum 
alanine transaminase, serum aspartate transaminase, serum 
glucose, and serum lactate dehydrogenase), urine, blood, 
and sputum examination through microscopy and culture, 
ultrasonography, X-ray. Since the study area is hyperendemic 
to malaria, all the study patients were screened for the same by 
immunochromatographic test.
The data were collected in an Excel sheet for further statistical 
analysis. The mean and standard deviation were calculated for 
all hematological parameters. Independent t-test was used for 
comparing the hematological and some physical examinations 
data between sickle cell disease patients with infection and 
without infection. GraphPad InStat Version 3.00 for Windows 
was used for all the statistical analysis. p<0.05 was considered to 
be statistically significant.
The mean age of the patients was 28.3±10.7 years (range: 
17–57 years) with 57.5% (23/40) being male. There was no 
statistical difference in the age of both genders. Out of 40 patients, 
19 patients were referred from peripheral hospitals. The mean 
hemoglobin, red blood cells, white blood cells, and platelets count 
were 7.49±2.47 g/dL, 3.08±1.03 (×106/μL), 10.4±6.1 (×103/ μL), 
and 191.5±120.8 (×103/μL),  respectively.  During  admission, 
the duration of hospital stay was 5.75±2.4 days. The mean and 
standard deviation along with range value of all the hematological, 
biochemical, and physical examination parameters have been 
illustrated in Table 1.
During admission, the patients with sickle cell disease showed 
different clinical signs and symptoms. Majority of patients had 
repeated episodes of painful events (65.0%) followed by fever 
(42.5%), jaundice (32.5%), severe anemia (30.0%), acute chest 
syndrome (12.5%), acute renal failure (10.0%) etc. Patients 
having severe anemia required a blood transfusion. A total of 35 
units of blood had transfused which raised the mean hemoglobin 
level from 4.15 g/dL to 8.8 g/dL. Ultrasonography results revealed 
17.5%, 10.0%, and 7.5% of patients had a large spleen, large 
liver, and gallstone, respectively. Similarly, X-ray results showed 
avascular necrosis in the femur in 2 patients (5.0%). Two patients 
had died. Both had episodes of painful events and infection (one 
patient had severe anemia with pneumonia whereas another had 
Plasmodium falciparum infection). The incidence of different 
clinical signs and symptoms in patients with sickle cell disease 
has been depicted in Table 2.
Urine or sputum or blood culture and a microscopic study 
showed 14 (35.0%) patients had infections. Malaria was 
diagnosed in 6 patients (P. falciparum in 4 patients, Plasmodium 
vivax in one patient, and both P. falciparum and vivax in one 
patient). Urinary tract infection was found in four patients. 
Pneumonia and acute calculous cholecystitis were reported 
in one patient each. Two patients had septicemia and both the 
patients were characterized by the presence of Escherichia coli 
found in blood culture.
Patients with infection had significantly low hemoglobin level 
and red blood cells counts whereas parameters such as white 
blood cells, lactate dehydrogenase, heart rate, body temperature, 
and duration of hospital stay were increased in patients with 
infection (Table 3). Out of 26 patients with an episode of painful 
events, 7 (26.9%) patients had infections.
Patients were discharged after appropriate treatment. Out 
of the 40 patients, 22 patients were under hydroxyurea therapy 
at a low and fixed dose of 10 mg/kg body weight/day before 
admission to the hospital. From the 22 patients, 10 patients had 
an infection and 7 patients had episodes of painful events. Acute 
chest syndrome, chronic kidney disease, viral fever, jaundice, and 
acute renal failure were reported in one patient each. Rest patients 
Table 1: Demographic, hematological, and clinical examination of 
the study patients (n=40)
Parameters Mean±SD Range
Mean age 28.3±10.7 18–57
Gender
Male 23 (57.5%)
Female 17 (42.5%)
Hemoglobin (g/dL) 7.49±2.47 2.1–11.3
Red blood cells (×106/μL) 3.08±1.03 0.71–6.2
White blood cells (×103/μL) 10.4±6.1 2.8–28.1
Platelets counts (×103/μL) 191.5±120.8 73–731
Glucose (U/L) 105.8±24.4 57–157
Serum urea (mg/dL) 43.2±32.5 10–143
Serum creatinine (mg/dL) 1.3±0.9 0.2–4.1
Serum bilirubin-total (mg/dL) 3.0±1.5 1.1–8.0
Serum bilirubin-direct (mg/dL) 1.02±0.6 0.3–2.8
Serum ALT (U/L) 56.8±45.2 16.8–216
Serum AST (U/L) 65.5±45.4 16.9–238
Serum lactate dehydrogenase (U/L) 706.2±488.1 213–2004
Diastolic blood pressure (number) 71.0±9.0 56–98
Systolic blood pressure (Number) 108.9±12.9 82–140
Heart rate (Number) 98.3±11.8 78–119
Temperature (°F) 99.7±2.3 98–104
Hospital stay (in days) 5.75±2.4 3–12
SD: Standard deviation, ALT: Alanine transaminase, AST: Aspartate transaminase
Table 2: The incidence of clinical signs and symptoms in the study 
population (n=40)
Clinical signs and symptoms Number (%)
Fever 17 (42.5)
Severe anemia 12 (30.0)
Painful events 26 (65.0)
Hepatomegaly 4 (10.0)
Cholelithiasis 3 (7.5)
Splenomegaly 7 (17.5)
Avascular necrosis 2 (5.0)
Jaundice 13 (32.5)
Acute chest syndrome 5 (12.5)
Acute renal failure 4 (10.0)
Chronic kidney disease 1 (2.5)
Death 2 (5.0)
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were enrolled for hydroxyurea therapy at a low dose as per the 
guidelines. The febrile patients were started with antibiotics 
Antibiotic treatment was modified as per the microbiological 
report and continued till patients’ afebrileness.
DISCUSSION
Sickle cell disease is a major public health problem in the Western 
districts of Odisha state with significant morbidity and mortality. 
The study population presented with varied clinical signs and 
symptoms. The majority had episodes of painful events (65.0%) and 
severe anemia required blood transfusion (30.0%). In a recent study 
undertaken in Riyadh, the authors have reported 84.0% and 28.3% 
of cases had episodes of painful events and anemia, respectively [6]. 
These varied clinical presentations can be explained by the different 
sickle haplotypes as evidenced by the differences in the clinical 
characteristics  [7-9]. The βS allele in the Indian patients is linked 
to Arab-Indian haplotypes which are characterized by the presence 
of a high HbF level with reduced clinical severity [10]. During 
hospitalization, these patients showed a high level of hemolysis 
which can be explained by low hemoglobin level with a high 
level of lactate dehydrogenase and bilirubin level. Raised lactate 
dehydrogenase level was found to be associated with increased 
episodes of painful events in patients with sickle cell disease [11,12]. 
In our study, patients with episodes of painful events also have 
significantly high lactate dehydrogenase level as compared to 
patients without painful events (median, 819 U/L versus 517 U/L).
Infection was a major cause of morbidity and mortality in 
patients with sickle cell disease that required hospitalization  [4,13]. 
Out of the 14 patients with infection, majority have urinary tract 
infection followed by malaria. The study area is hyperendemic to 
malaria and contributes to significant morbidity and mortality in 
patients with sickle cell disease. In a recent hospital-based study 
undertaken in our institution, the mortality rate was significantly 
high  (χ2=10.48; p<0.001) in malaria patients with sickle cell 
disease  compared  to  normal  β-globin  genotype  [14].  Bacterial 
infection was reported in nine patients in this study. In an earlier 
study carried out in patients with sickle cell disease in this 
institution different strains of bacterial infections have also been 
recorded [15]. Patients with infection had low hemoglobin level 
with high lactate dehydrogenase level implying a higher rate of 
hemolysis in these patients compared to those without infection. 
Infection was the precipitating factor for painful events in 26.9% 
of patients. Patients with fever were started antibiotics, and the 
antibiotics were modified according to the microbiological reports.
Hydroxyurea therapy has been used significantly for the 
reduction in the rate of painful events and recruitment of blood 
transfusion and other severity in patients with sickle cell disease. 
Surprisingly, 55.0% (22/40) of patients were found under 
hydroxyurea therapy before admission to the hospital. Except 
for infections and chronic kidney disease, 10 patients were 
found irregular on hydroxyurea treatment follow-up. Death was 
recorded in two patients. Pneumonia and P. falciparum malaria 
was the cause of death. Death due to P. falciparum malaria in 
patients with sickle cell disease has been reported from this 
institution in an earlier study [14].
CONCLUSION
Painful events and severe anemia were two major clinical 
severities responsible for the hospitalization of patients with sickle 
cell disease. Infection such as bacterial and malaria accelerate 
the severity leading to higher morbidity and mortality in patients 
with sickle cell disease. It is important for the early choice of 
Table 3: Comparison of hematological and physical examination parameters between sickle cell disease patients with and without infection
Parameters With infection (n=14) Without infection (n=26) Independent test 
p value
Hemoglobin (g/dL) 6.0±2.3 8.3±2.2 0.0032*
Red blood cells (×106/μL) 2.58±0.95 3.35±1.0 0.022*
White blood cells (×103/μL) 15.4±6.5 5.3±1.5 <0.0001*
Platelets counts (×103/μL) 229.5±164.3 170.4±86.2 0.14
Glucose (U/L) 106.2±22.7 106.7±22.8 0.94
Serum urea (mg/dL) 46.7±23.2 44.5±36.9 0.73
Serum creatinine (mg/dL) 1.4±0.75 1.2±1.0 0.53
Serum bilirubin-total (mg/dL) 3.3±1.6 2.8±1.4 0.36
Serum bilirubin-direct (mg/dL) 1.1±0.7 1.0±0.54 0.57
ALT (U/L) 43.5±22.0 58.9±49.4 0.25
AST (U/L) 51.3±18.8 66.5±42.4 0.21
Lactate dehydrogenase (U/L) 936.9±552.7 581.9±408.8 0.026*
Diastolic blood pressure (mm-Hg) 68.2±8.3 72.5±9.2 0.088
Systolic blood pressure (mm-Hg) 104.1±12.9 111.4±12.4 0.158
Heart rate (beats per minute) 107.6±6.4 93.3±10.9 <0.0001*
Temperature (°F) 102.3±1.7 98.3±0.9 <0.0001*
Duration of hospital stay (in days) 7.6±2.2 4.7±1.4 <0.0001*
*p<0.05 (statistical significance). ALT: Alanine transaminase, AST: Aspartate transaminase
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appropriate antibiotics and other chemoprophylaxis to combat the 
disease severity due to infection in patients with sickle cell disease.
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